Trial intelligence / Profile preview

Magnesium Sulfate to Reduce Atrial Fibrillation After Coronary Artery Bypass Surgery: Dose-Finding Randomized Trial

TCTR20140122001Phase 4Completed

Sponsor
No
Start
Aug 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of magnesium sulfate in Atrial fibrillation (AFib), sponsored by No. Started Aug 2008; status: completed.

02

Drugs

magnesium sulfate
03

Conditions

Atrial fibrillation (AFib)

Beyond the preview

Go deeper on TCTR20140122001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20140122001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call